ACTICOR BIOTECH

acticor-biotech-logo

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke. Acticor Biotechโ€™s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million dies and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It... is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However, only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less than 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains. Acticor Biotech was founded in November 2013 and is headquartered in Paris, France.

#SimilarOrganizations #People #Financial #Website #More

ACTICOR BIOTECH

Social Links:

Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics

Founded:
2010-01-01

Address:
Paris, Ile-de-France, France

Country:
France

Website Url:
http://www.acticor-biotech.com

Total Employee:
11+

Status:
Active

Contact:
+33970468640

Email Addresses:
[email protected]

Total Funding:
33.2 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Euro Microsoft Exchange Online


Similar Organizations

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.


Current Advisors List

alain-munoz_image

Alain Munoz Chairman of the Board @ Acticor Biotech
Board_member
2021-04-01

not_available_image

Hyun Tae Kim Board Of Director @ Acticor Biotech
Board_member

alain-parthoens_image

Alain Parthoens Board Of Director @ Acticor Biotech
Board_member

not_available_image

Timur Avdeenko Observer of the Board @ Acticor Biotech
Board_observer

Current Employees Featured

olivier-favre-bulle_image

Olivier Favre-Bulle
Olivier Favre-Bulle Head of Product Development and Manufacturing (acting) @ Acticor Biotech
Head of Product Development and Manufacturing (acting)
2016-01-01

philippe-billiald_image

Philippe BILLIALD
Philippe BILLIALD Scientific Advisor @ Acticor Biotech
Scientific Advisor
2013-11-01

eric-cohen_image

Eric Cohen
Eric Cohen CFO @ Acticor Biotech
CFO

gilles-avenard_image

Gilles Avenard
Gilles Avenard CEO @ Acticor Biotech
CEO
2014-10-01

yannick-pletan_image

Yannick Pletan
Yannick Pletan CMO @ Acticor Biotech
CMO

Founder


antoine-reveau_image

Antoine Reveau

gilles-avenard_image

Gilles Avenard

Stock Details


Company's stock symbol is EPA:ALACT

Investors List

anaxago_image

Anaxago

Anaxago investment in Series B - Acticor Biotech

newton-biocapital_image

Newton Biocapital

Newton Biocapital investment in Series B - Acticor Biotech

a-b-hk_image

A&B (HK)

A&B (HK) investment in Series B - Acticor Biotech

karista_image

Karista

Karista investment in Series B - Acticor Biotech

mirae-asset-global-investments_image

Mirae Asset Global Investments

Mirae Asset Global Investments investment in Series B - Acticor Biotech

cms-medical-venture-investment_image

CMS Medical Venture Investment

CMS Medical Venture Investment investment in Series B - Acticor Biotech

ouest-ventures_image

GO CAPITAL

GO CAPITAL investment in Series B - Acticor Biotech

mirae-capital_image

Mirae Capital

Mirae Capital investment in Series B - Acticor Biotech

newton-biocapital_image

Newton Biocapital

Newton Biocapital investment in Series B - Acticor Biotech

cms-medical-venture-investment_image

CMS Medical Venture Investment

CMS Medical Venture Investment investment in Series B - Acticor Biotech

Official Site Inspections

http://www.acticor-biotech.com Semrush global rank: 3.84 M Semrush visits lastest month: 3.42 K

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Acticor Biotech" on Search Engine